Market Closed -
Nasdaq
03:59:48 2024-06-04 pm EDT
5-day change
1st Jan Change
107.7
USD
-2.59%
+2.68%
+7.99%
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to the ICU Medical...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
ICU Medical Insider Sold Shares Worth $1,303,485, According to a Recent SEC Filing
May. 31
MT
ICU Medical's Q1 Adjusted Earnings, Revenue Decline
May. 08
MT
Earnings Flash (ICUI) ICU MEDICAL Reports Q1 Revenue $566.7M, vs. Street Est of $554M
May. 07
MT
Earnings Flash (ICUI) ICU MEDICAL Posts Q1 EPS $0.96, vs. Street Est of $0.82
May. 07
MT
ICU Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 07
CI
Transcript : ICU Medical, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07
ICU Medical, Inc. Provides Updated Unaudited Earnings Guidance for the Year 2024
May. 07
CI
Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Mar. 20
Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing
Mar. 15
MT
Icu Medical Insider Sold Shares Worth $4,386,155, According to a Recent SEC Filing
Mar. 11
MT
ICU Medical, Inc. Announces the Resignation of Bill Seeger as Nominated Director
Mar. 07
CI
Icu Medical Insider Sold Shares Worth $1,458,090, According to a Recent SEC Filing
Mar. 05
MT
Transcript : ICU Medical, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 07:30 AM
Mar. 04
Smiths Group Confirms $88 Million Sale of ICU Medical Stake
Mar. 01
MT
ICU Medical, Inc. Announces Resignation of William Seeger from Board of Director and Member of the Audit and Compliance Committee
Feb. 29
CI
An unknown buyer completed the acquisition of 3.44% stake in ICU Medical, Inc. (NasdaqGS : ICUI) from Smiths Group International Holdings Ltd. for $88.042 million.
Feb. 28
CI
KeyBanc Adjusts Price Target on ICU Medical to $136 From $134, Maintains Overweight Rating
Feb. 28
MT
ICU Medical's Q4 Adjusted Earnings Decline While Revenue Increases; Sets 2024 Adjusted Profit Guidance
Feb. 28
MT
ICU Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 27
CI
Transcript : ICU Medical, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Feb. 27
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 Revenue $587.9M, vs. Street Est of $568.3M
Feb. 27
MT
Earnings Flash (ICUI) ICU MEDICAL Reports Q4 EPS $1.57, vs. Street Est of $1.19
Feb. 27
MT
ICU Medical, Inc. Provides Earnings Guidance for the Fiscal Year 2024
Feb. 27
CI
ICU Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 27
CI
CL King Starts ICU Medical With Buy Rating, $110 Price Target
Dec. 14
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
More about the company
Last Close Price
107.7
USD
Average target price
142.2
USD
Spread / Average Target
+32.13%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1